摘要
医药产业是大健康产业重要的组成部分,归根到底是为大健康服务的,它将因循健康产业的发展做出调整。中国医药产业在全球医药市场中发挥着越来越重要的作用,自2013年起成为仅次于美国的全球第二大药品市场,为世界上最大的化学原料药出口国。医药行业主营业务收入增长低于10%,但仍高于其他行业。山东省是医药大省,但不是医药强省,企业创新能力不足,新旧动能转换、结构调整任重道远。依照"十二五"和"十三五"全国与山东省医药发展态势,分析当前医药产业发展面临的新变化,按照行业运行数据研究大健康产业未来发展方向和重点,提出医养结合将是未来发展方向。建立医养结合等行业跨界融合的产品结构和营销模式成为新趋势,努力从传统药品营销转为健康服务为主的新型医药企业。
The pharmaceutical industry is an important part of the health industry and ultimately serves the general health industry, which therefore requires adjustments based on the development of the health industry. The Chinese pharmaceutical industry has played an increasingly important role in the global pharmaceutical market. Since 2013, it has become the world＇ s second largest pharmaceutical market after the United States, and it is the world＇s largest exporter of chemical APIs. The main business income growth of the pharmaceutical industry is less than 10%, but it is still higher than that in other industries. Shandong is a large but not strong province of medicine. There is a long way to go for it because of its lack of innovation ability of enterprises and heavy task of the transformation from old to new drivers and structural adjustment. In accordance with the trend of pharmaceutical development in the country and Shandong Province during the ＂ 12th Five-Year＂ and ＂ 13th Five-Year Plan＂ period, the article analyzes the current changes and studies the direction and focus of future development of the large-scale health industry based on industry operational data, and finally puts forward the combination of heahhcare and pension as the future development direction. Nowadays, it has become a new trend to establish an integration product structure and marketing model in the pension and healthcare industry, and shift from traditional medicine marketing to new-type pharmaceutical companies focusing on health services.
作者
王唯佳
WANG Weijia(Shandong Pharmaceutical Profession Association, Jinan Shandong Province250013, Chin)
出处
《中国发展》
2018年第1期13-18,共6页
China Development
关键词
医药
大数据
健康
产业
发展
medicine
big data
health
industry
development
